抗体-药物结合物(ADC)由理想的单克隆抗体、活性细胞毒性药物和合适的连接剂组成。抗体和细胞毒性药物之间的适当连接物提供特异性桥,从而帮助抗体选择性地将细胞毒性药物递送至肿瘤细胞,并在肿瘤部位精确地释放细胞毒性药物

清空选项
16024-58-1 2-(2-(2-Methoxyethoxy)ethoxy)acetic acid 2-(2-(2-甲氧基乙氧基)乙氧基)乙酸
BD6905316024-58-198%
¥1670.0025g
206265-98-7 tert-Butyl (23-amino-3,6,9,12,15,18,21-heptaoxatricosyl)carbamate (23-氨基-3,6,9,12,15,18,21-七氧三十二烷基)氨基甲酸叔丁酯
BD434440206265-98-798%
¥1045.00250mg
882847-32-7 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid 5,8,11,14,17-五氧杂-2-氮杂二十碳二酸-1-(9H-芴-9-基甲基)酯
BD250101882847-32-795%
¥3083.005g
1093647-41-6 2,5,8,11,14,17,20,23-Octaoxahexacosan-26-oic acid 2,5,8,11,14,17,20,23-八氧杂二十六烷-26-酸
BD4345181093647-41-698%
¥1304.001g
361189-64-2 tert-Butyl 1-hydroxy-3,6,9,12,15,18-hexaoxahenicosan-21-oate 1-羟基-3,6,9,12,15,18-六氧杂二十一烷-21-酸叔丁酯
BD760126361189-64-298%
¥867.001g
1530778-24-5 Tos-PEG3-CH2COOtBu 2-(2-(2-(2-(对甲苯磺酰氧基)乙氧基)乙氧基)乙氧基)乙酸叔丁酯
BD008162991530778-24-597%
¥695.001g
1556847-53-0 tert-Butyl (32-hydroxy-3,6,9,12,15,18,21,24,27,30-decaoxadotriacontyl)carbamate (32-羟基-3,6,9,12,15,18,21,24,27,30-十氧杂三十烷基)氨基甲酸叔丁酯
BD008420981556847-53-095%
¥3980.001g
1526718-98-8 Bis(2,5-dioxopyrrolidin-1-yl) 4,7,10,13,16,19-hexaoxadocosanedioate 双(2,5-二氧代吡咯烷-1-基) 4,7,10,13,16,19-六氧杂二十二烷二酸酯
BD008261381526718-98-895%
¥667.001g
2055042-66-3 Hydroxy-PEG9-t-butyl ester 羟基九聚乙二醇丙酸叔丁酯
BD008325822055042-66-395%
¥463.00100mg
2112731-42-5 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25-heptaoxa-4-azaoctacosan-28-oic acid 1-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)-3-氧代-7,10,13,16,19,22,25-七氧杂-4-氮杂二十八烷-28-酸
BD008484492112731-42-595%
¥1543.001g
1974310-58-1 2,2'-Bithiophene, 5,5'-dibromo-3,3'-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]- 5,5'-二溴-3,3'-双s(2-(2-(2-甲氧基乙氧基)乙氧基)乙氧基)-2,2'-联噻吩
BD011816021974310-58-197%
¥635.00100mg
1334169-93-5 2,2-Dimethyl-4-oxo-3,8,11,14,17,20,23,26,29-nonaoxa-5-azadotriacontan-32-oic acid 2,2-二甲基-4-氧代-3,8,11,14,17,20,23,26,29-九氧杂-5-氮杂三十二烷-32-酸
BD011209401334169-93-595%
¥262.00100mg
1778736-18-7 N-(2-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide N-(2-(2-(2-(2-羟基乙氧基)乙氧基)乙氧基)乙基)-5-((3aS,4S,6aR)-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰胺
BD008323501778736-18-795%
¥3962.001g
2576495-35-5 2,5,8,11,14,17,20,23,26-Nonaoxanonacosan-29-oic acid 2,5,8,11,14,17,20,23,26-九氧杂二十九烷-29-酸
BD008366442576495-35-595%
¥933.001g
N/A NH2-PEG-RhB 氨基-聚乙二醇-RhB
BD01405525N/A97% average Mw550
¥666.00100mg
2411381-38-7 NH2-PEG-FITC 氨基-聚乙二醇-FITC
BD014040622411381-38-797% average Mw550
¥929.0050mg
N/A Mal-PEG-RhB 马来酰亚胺-聚乙二醇-RhB
BD01401539N/A97% average Mw550
¥529.00100mg
1845706-65-1 Mal-PEG-FITC 马来酰亚胺-聚乙二醇-FITC
BD014244661845706-65-197% average Mw550
¥880.0050mg
N/A Mal-PEG-FA 马来酰亚胺-聚乙二醇-叶酸
BD01408139N/A97% average Mw550
¥978.0050mg
1207751-12-9 Mal-PEG-NH2 马来酰亚胺-聚乙二醇-氨基
BD013812671207751-12-997% average Mw2000
¥291.00100mg
1 2 3 4 5 6 7 8 9 ... 65